The interplay between genetics, the microbiome, DNA‐methylation & gene‐expression
Many factors are involved in the development of human diseases and traits. In recent years the field of human genetics has been very successful in linking genetic variation to diseases and traits. By conducting large-scale studies comparing the genetic make-up of affected versus non-affected participants, we have identified thousands of variants in the human genome that are more or less commonly found in cases compared to controls. These genome-wide association studies (GWAS) have been instrumental in the identification of genes linked to a multitude of diseases and traits. Some variants in the functional parts of a gene can be relatively straightforward to interpret, but no all. By using intermediate molecular data layers, such as gene expression, DNA-methylation or protein levels, we can gain more insight into the genetic variants identified by GWAS.
However, we only get a limited picture of disease by focusing on genetic variation. Another important factor related to disease is the environment. It is much harder to quantify environmental factors than to determine the genetic differences between two individuals. Using the intermediate molecular data, or biological omics, we can gain insights into the environment of individuals. The environment surrounding individuals can, for instance, influence the composition of their microbiome, but also their gene expression, DNA-methylation and protein levels. By studying the differences in these biological omics in relation to phenotypes and disease, we can learn more about the environmental factors that lead to disease. However, as with GWAS studies, we do not always know what the differences in these biological data layers mean.
In this thesis we have focused on two biological omics, the gut microbiome and the DNA-methylome. The gut microbiome is the collection of micro-organisms that live together in the human gut; DNA-methylation is the occurrence of a methyl group bound to the DNA and this mainly occurs at cysteine-guanine pairs.